Metraipolis › archive › dc_bf727b9c9983

Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov — Europe PMC PMID:41450882

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41450882
DOI
10.3389/fped.2025.1695990
License (as archived)
solo-consultazione
Archived
2026-11-07T18:26:15.094Z
SHA-256 of the archived text
023d79903d81c926373ee3485ffe77d92a7e1ba159fc74ebf00e712fd43ff17b
Stable URL of this page
https://metraipolis.com/documento/dc_bf727b9c9983

How to cite

Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov — Europe PMC PMID:41450882 — Europe PMC (en), https://europepmc.org/article/MED/41450882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf727b9c9983 (Metraipolis archive dc_bf727b9c9983, sha256 023d79903d81c926373ee3485ffe77d92a7e1ba159fc74ebf00e712fd43ff17b)
BibTeX
@misc{dcbf727b9c9983,
  title = {Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov — Europe PMC PMID:41450882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41450882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf727b9c9983; sha256 023d79903d81c926373ee3485ffe77d92a7e1ba159fc74ebf00e712fd43ff17b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41450882. Agents can read the archived copy with the MCP tool read_document.